Stocks and Investing Stocks and Investing
Fri, March 16, 2018
Thu, March 15, 2018

Sumant Kulkarni Maintained (VYGR) at Strong Buy with Decreased Target to $35 on, Mar 15th, 2018


Published on 2024-10-26 03:50:47 - WOPRAI, Sumant Kulkarni
  Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Maintained "Voyager Therapeutics, Inc." (VYGR) at Strong Buy with Decreased Target from $36 to $35 on, Mar 15th, 2018.

Sumant has made no other calls on VYGR in the last 4 months.



There are 4 other peers that have a rating on VYGR. Out of the 4 peers that are also analyzing VYGR, 2 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Nierengarten of "Wedbush" Downgraded from Buy to Hold on, Monday, March 12th, 2018
  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, March 12th, 2018


These are the ratings of the 2 analyists that currently disagree with Sumant


  • Jeffrey Hung of "Morgan Stanley" Maintained at Buy with Increased Target to $39 on, Wednesday, February 21st, 2018
  • Dane Leone of "BTIG" Initiated at Strong Buy and Held Target at $32 on, Wednesday, December 20th, 2017

Contributing Sources